A 67-year-old patient will be undergoing a mitral valve replacement for severe mitral valve stenosis. When reviewing the patient's chart, which of these infectious diseases would likely to be present in this patient's history?

A. Smoking is a significant risk factor for the development of AAA. It contributes to the degradation of elastin and collagen in the arterial wall, which weakens the aorta and increases the risk of aneurysm formation. Smokers have a higher incidence of AAA compared to non-smokers.
B. A family history of aneurysms is another important risk factor. Genetic predisposition can increase the likelihood of developing AAA, indicating that the condition may run in families. Individuals with a family history of AAA are at higher risk and should be monitored more closely.
C. High-density lipoprotein (HDL) cholesterol is often referred to as "good" cholesterol because it helps remove excess cholesterol from the bloodstream. Higher levels of HDL cholesterol are generally considered protective against cardiovascular diseases, including AAA.
D. Total cholesterol levels are used to assess cardiovascular risk. A total cholesterol level of 170 mg/dL is within the normal range (less than 200 mg/dL). While high cholesterol can contribute to cardiovascular diseases, a total cholesterol level of 170 mg/dL is not considered a risk factor for AAA.
E. Diabetes mellitus is not typically considered a direct risk factor for AAA. However, diabetes is a risk factor for atherosclerosis, which can contribute to various vascular conditions.

A. Digoxin is a medication used primarily to treat heart failure and certain types of arrhythmias, such as atrial fibrillation. It works by increasing the force of heart contractions and slowing the heart rate. However, digoxin is not typically used to treat bradycardia and may actually exacerbate the condition by further slowing the heart rate.
B. While monitoring is an essential part of patient care, it is not sufficient alone in this situation. The client’s heart rate is very low (45 beats per minute) and their blood pressure is low (82/60 mm Hg), which suggests they are symptomatic and potentially unstable.
C. Defibrillation is used to treat life-threatening arrhythmias such as ventricular fibrillation or pulseless ventricular tachycardia. It is not used for sinus bradycardia, which is a slow heart rate rather than a rapid, disorganized rhythm requiring electrical shock.

D. Transcutaneous pacing involves applying external pacing pads to the skin to stimulate the heart and increase the heart rate. This is a suitable intervention for symptomatic bradycardia, especially when accompanied by low blood pressure and dizziness.